The skin loses its tight, firm and young look with the passage of time. Fortunately, Sculptra can help smooth wrinkles and restore the lost skin volume in a natural way. The injection of wrinkles with the polylactic acid Sculptra leads to a good-looking shaping of the facial contour and can eliminate bothersome wrinkles without the risks of an operation.
Polylactic acid has been in successful use in surgery for over 25 years as a base for medicines, among other uses. Sculptra was specifically developed to eliminate contour defects in the face. Roughly 150,000 patients have been treated worldwide since 1999. Sculptra has a long-lasting effect and is well tolerated.
In contrast to surgical interventions, the treatment with Sculptra is less traumatic and leads to progressive, naturally looking results.
This procedure has minimal side effects. Sometimes swelling or blood collections develop at the injection sites. These resolve in a couple of days in most cases. Clinical studies have shown that the aesthetic results reached with Sculptra last in many patients up to 2 years.
Sculptra acts on the layers of the skin to smooth and tighten the treated areas of the face. Sculptra is a substance that is broken down slowly and naturally by the body. Sculptra is not of animal origin, so no allergy test is necessary before the treatment.
In general, areas of wrinkles of the cheeks and around the mouth are targeted. The interesting feature in its mode of action is a remarkable stimulation of the building of new natural collagen fibres. The skin becomes markedly firmer and more elastic. Depending on the extent of the wrinkles, another injection (after about 6 weeks) could be necessary for a good result.
Sculptra is designed for patients who wish to preserve the natural look of their faces or to smooth out progressive age-related changes, for instance loose or wrinkly skin. It is suitable for patients between the ages of 35 and 50 who are not yet candidates for a facelift and in whom other substances do not produce satisfactory results.